Pathway Pharmaceuticals

Pathway Pharmaceuticals has combined the most innovative techniques in genetics, systems biology, bioinformatics, and molecular biology to create an original groundbreaking technology that enables us to discover the most effective available treatment plan for each individual patient’s particular case. We are the only company currently undertaking this kind of exclusive molecular analysis of patients’ tissue samples, consisting of: complete transcriptome profiling (i.e. analysis of aberrantly active vs. inactive genes), analysis of affected intracellular molecular signaling pathways, and establishment of which of the currently available targeted therapies is expected to most efficiently stop each individual patient’s tumor.